ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

UCSF. Roswell Park Win National Cooperative Drug Discovery Group Awards; RFA To Be Reissued

June 15, 1984

$150 Mil. For Army Breast Cancer Program Urged In Letter

September 16, 1994

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989

NCI Cooperative Group Clinical Trials Approved

August 27, 2010